Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Chemosaturation therapy for cancers in the liver

17th ECCO - 38th ESMO - 32nd ESTRO European Cancer Congress (ECC 2013)

Published: 11 Nov 2013

Views: 7019

Rating:

Save

Dr Stephen Fenwick - Aintree University Hospital, Liverpool, UK

Dr Stephen Fenwick talks to ecancer about chemosaturation therapy; what patients it can be used for, expected treatment outcomes and the therapy's future in overall treatment.

Related Videos

Administering systemic chemotherapy improves survival for patients with resectable CRCLM

Dr Giacomo Bregni - Francis Crick Institute, London, England

Administering systemic chemotherapy improves survival for patients with resectable CRCLM ( Dr Giacomo Bregni - Francis Crick Institute, London, England )

Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in multiple myeloma patients

Dr Claudio Cerchione - IRCCS, Meldola, Italy

Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in multiple myeloma patients ( Dr Claudio Cerchione - IRCCS, Meldola, Italy )

Trial argues strongly for the development of 1st-line biomarker selected strategies in pancreatic ductal adenocarcinoma

Prof Jennifer Knox - University of Toronto, Toronto, Canada

Trial argues strongly for the development of 1st-line biomarker selected strategies in pancreatic ductal adenocarcinoma ( Prof Jennifer Knox - University of Toronto, Toronto, Canada )

Relapsed refractory multiple myeloma

Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India

$Relapsed refractory multiple myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )$

Intra-arterial gemcitabine and IV gemcitabine/nab-paclitaxel show similar SAEs in locally advanced pancreatic cancer

Dr Michael Pishvaian - Johns Hopkins Kimmel Cancer Center, Washington DC, USA

Intra-arterial gemcitabine and IV gemcitabine/nab-paclitaxel show similar SAEs in locally advanced pancreatic cancer ( Dr Michael Pishvaian - Johns Hopkins Kimmel Cancer Center, Washington DC, USA )

ASCO 2023: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ASCO 2023: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

HCC: Improvement in RFS for atezolizumab plus bevacizumab vs active surveillance without compromising QoL

Prof Masatoshi Kudo - Kindai University, Higashiōsaka, Japan

HCC: Improvement in RFS for atezolizumab plus bevacizumab vs active surveillance without compromising QoL ( Prof Masatoshi Kudo - Kindai University, Higashiōsaka, Japan )

More from ecancer